Bayforest Capital’s Johnson & Johnson JNJ Stock Holding History

Bayforest Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8	Closed	-$1.66K	–	1001
2025 Q4	$1.66K	Buy	+8	New	+$1.58K	﹤0.01%	746
2025 Q3	–	Sell	-409	Closed	-$62.5K	–	829
2025 Q2	$62.5K	Sell	409 -3,739	-90%	-$575K	0.03%	515
2025 Q1	$688K	Buy	4,148 +3,082	+289%	+$482K	0.3%	93
2024 Q4	$154K	Buy	+1,066	New	+$165K	0.19%	191

Other funds holding JNJ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bayforest Capital's JNJ Position: Q1 2026 in Review

Bayforest Capital sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 8 shares — an estimated $1.66K sold.

Bayforest Capital first reported a position in JNJ in Q4 2024 and held it in 4 quarters. The position peaked at $688K in Q1 2025. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

Bayforest Capital reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
Bayforest Capital sold 8 Johnson & Johnson shares in Q1 2026, an estimated $1.66K.
Bayforest Capital first reported a position in Johnson & Johnson in Q4 2024 and held it in 4 quarters.
Bayforest Capital's Johnson & Johnson position peaked at $688K in Q1 2025.
4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Bayforest Capital's 13F filing for Q1 2026, filed 15 Apr 2026.